Ligand Pharmaceuticals, Inc. (LGND) Stock Forecast & Predictions

Ligand Pharmaceuticals, Inc. - Class B LGND: $143.785

3911 Sorrento Valley Blvd Ste 110, San Diego, California, US. | Sector: Manufacturing | Exchange: NASDAQ/NMS (GLOBAL MARKET) | Web:

  • Market Cap$2.42B
  • Change (52 Weeks)59.85%
  • Low (52 Weeks)$78.26
  • Ligand Pharmaceuticals, Inc. (LGND) Forecast Based on Technical Analysis

    Based on 16 Technical Indicators where 25.00% are on Buy, 25.00% on Sell, and 50.00% Neutral.

    According to the market data, Ligand Pharmaceuticals, Inc. (LGND) stock price is $143.785 and the 52 weeks low is $78.26, which means the Ligand Pharmaceuticals, Inc. stock price is up 59.85% in the last 12 months.

    Ligand Pharmaceuticals, Inc. (LGND) Stock Price has been Trending Strongly with an ADX reading of 30.90 as per the Weekly Chart.

    A Upward trend indicates that Ligand Pharmaceuticals, Inc. (LGND) Stock Price may keep going up, with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors).

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 25.00% are indicating that LGND Stock price might rise further, 25.00% indicating that LGND Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall LGND stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Ligand Pharmaceuticals, Inc. (LGND) Stock Forecast By Analysts

    Strong Buy
    Analysts Recommendations for Ligand Pharmaceuticals, Inc. (LGND) is based on 14 Institutional Analyst Ratings where 64.29% are on Strong Buy, 14.29% on Moderate Buy, 21.43% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 14 Institutional Analysts, majority recommended LGND stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Ligand Pharmaceuticals, Inc..

    Ligand Pharmaceuticals, Inc. (LGND) Stock Price Prediction By Analysts

    $229.1659.38% Upside
    Updated: 2021-04-12 00:00:00

    The Average Price target for LGND set by the institutional analysts is $229.16 where High Estimate is $325.50, Median $216.75 and Low $199.98.

    The average price target for LGND by Institutional Analysts is $229.16, which is 59.38% Upside from the current price. So according to the Institutional Analysts, LGND Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Ligand Pharmaceuticals, Inc. (LGND) Stock Forecasts By Institutional Analysts

    Roth CapitalBuyMaintained
    HC Wainwright & Co.BuyMaintained
    Roth CapitalBuyReiterated
    HC Wainwright & Co.BuyMaintained
    Argus ResearchHoldDowngraded
    Guggenheim SecuritiesNeutralInitiated
    H.C. WainwrightBuyMaintained
    Goldman SachsNeutralInitiated
    Roth CapitalNeutralDowngraded
    H.C. WainwrightBuyMaintained
    H.C. WainwrightBuyMaintained
    Deutsche BankSellDowngraded
    H.C. WainwrightBuyMaintained
    Deutsche BankHoldMaintained
    Deutsche BankHoldMaintained
    Deutsche BankHoldUpgraded
    Deutsche BankSellDowngraded
    Stephens & Co.OverweightInitiated
    Roth CapitalBuyMaintained
    H.C. WainwrightBuyInitiated
    Roth CapitalBuyMaintained
    CJS SecuritiesMarket PerformMaintained
    Cantor FitzgeraldHoldMaintained
    Deutsche BankHoldDowngraded
    Cantor FitzgeraldHoldMaintained
    CRT CapitalBuyInitiated
    Deutsche BankBuyInitiated
    Empire Asset ManagementSellInitiated
    Brinson PatrickOutperformInitiated
    McNicoll Lewis VlakBuyMaintained
    Brean CapitalHoldDowngraded
    Cantor FitzgeraldSellDowngraded
    Cantor FitzgeraldHoldMaintained
    Cantor FitzgeraldHoldDowngraded
    Cantor FitzgeraldBuyMaintained

    Ligand Pharmaceuticals, Inc. (LGND) Stock Earning Per Share (EPS) Forecast / Estimate

    The average consensus EPS for LGND is $1.518 with a high estimate of $1.774 and Low of $1.254 for the period 2021-06-30 and based on 8 Institutional Analysts.

    Last Quarter


    The latest average Earning Per Share Estimate for Ligand Pharmaceuticals, Inc. is $1.52, which is higher than LGND's last EPS, $1.04. This means that Analysts are expecting Ligand Pharmaceuticals, Inc. to report higher earnings. This can drive share prices higher since the investors have positive sentiment about market performance of Ligand Pharmaceuticals, Inc..

    Earning Per Share (EPS) History


    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).